Checkpoint Therapeutics Inc (CKPT)
1.650
-0.04
(-2.36%)
USD |
NASDAQ |
May 08, 14:44
Checkpoint Therapeutics Profit Margin (Quarterly): -318.8K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -318.8K% |
| September 30, 2023 | -18.46K% |
| June 30, 2023 | -53.29K% |
| March 31, 2023 | -29.93K% |
| December 31, 2022 | -28.41K% |
| September 30, 2022 | -22.11K% |
| June 30, 2022 | -78.57K% |
| March 31, 2022 | -32.40K% |
| December 31, 2021 | -186.0K% |
| September 30, 2021 | -38.84K% |
| June 30, 2021 | -5.90K% |
| March 31, 2021 | -9.57K% |
| December 31, 2020 | -37.87K% |
| September 30, 2020 | -17.61K% |
| June 30, 2020 | -11.06K% |
| March 31, 2020 | -337.6% |
| December 31, 2019 | -35.30K% |
| Date | Value |
|---|---|
| September 30, 2019 | -1.86K% |
| June 30, 2019 | -455.9% |
| March 31, 2019 | -1.67K% |
| December 31, 2018 | -383.3% |
| September 30, 2018 | -186.9K% |
| June 30, 2018 | -5.23K% |
| March 31, 2018 | -2.56K% |
| December 31, 2017 | -1.78K% |
| September 30, 2017 | -1.70K% |
| June 30, 2017 | -1.84K% |
| March 31, 2017 | -632.5% |
| December 31, 2016 | -1.67K% |
| September 30, 2016 | -939.2% |
| June 30, 2016 | -432.7% |
| March 31, 2016 | -1.30K% |
| December 31, 2015 | -12.39K% |
| September 30, 2015 | -15.00K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-318.8K%
Minimum
Dec 2023
-337.6%
Maximum
Mar 2020
-48.78K%
Average
-28.41K%
Median
Dec 2022
Profit Margin (Quarterly) Benchmarks
| Anavex Life Sciences Corp | -- |
| QuidelOrtho Corp | 0.94% |
| Fortress Biotech Inc | -46.52% |
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -738.1% |
| Operating Margin (Quarterly) | -169.5K% |